Target intelligence / Profile preview

Microcystin (MC)

Target
MC
Molecular classification
Cyclic heptapeptide, Bacterial toxin, Secondary metabolite, Non-ribosomal peptide
01

Overview

Microcystins are a diverse family of cyclic heptapeptide toxins produced by various genera of cyanobacteria, most notably Microcystis, Anabaena, and Planktothrix, often occurring during harmful algal blooms. These toxins are characterized by a unique amino acid side chain known as Adda (3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid), which is essential for their biological activity and toxicity [1][2]. In humans and animals, microcystins primarily target the liver because they are actively transported into hepatocytes via organic anion transporting polypeptides (OATPs) [2][3]. Inside the cell, microcystins act as potent inhibitors of serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A), leading to unregulated protein phosphorylation, disruption of the actin cytoskeleton, and subsequent liver damage or tumor promotion [4][5]. While microcystins are not therapeutic targets in the traditional sense, they are critical environmental health hazards and are used in biochemical research to study phosphatase-regulated signaling pathways. Exposure to microcystins is associated with acute hepatotoxicity and has been linked to an increased risk of primary liver cancer in populations with contaminated drinking water sources [3][6]. Citations: [1] PubChem CID 100742; [2] EPA Health Effects Support Document (2015); [3] WHO Guidelines for Drinking-water Quality; [4] MacKintosh et al. (1990) FEBS Letters; [5] Zhou et al. (2015) Int. J. Environ. Res. Public Health; [6] IARC Monograph Vol 94.

Other names
CyanoginosinMicrocystin-LRMC-LRCyanobacterial toxinHepatotoxinCyclic heptapeptide toxin
02

Mechanism of action

Microcystins exert toxicity by potently and irreversibly inhibiting the catalytic subunits of serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A) through covalent binding. This inhibition leads to a massive hyperphosphorylation of cellular proteins, particularly those involved in maintaining the cytoskeleton, which causes hepatocytes to shrink, lose their shape, and eventually undergo apoptosis or necrotic cell death, leading to intrahepatic hemorrhage.

03

Biological functions

Inhibition of protein phosphatase 1 (PP1)Inhibition of protein phosphatase 2A (PP2A)Induction of oxidative stressDisruption of the actin cytoskeletonPromotion of apoptosisInhibition of DNA repair
04

Disease associations

HepatotoxicityLiver cancer (Hepatocellular carcinoma)Acute liver failureGastroenteritisKidney injuryNeurotoxicity
05

Safety considerations

Potent acute toxicity and lethalityClassification as a Group 2B possible human carcinogen by IARCBioaccumulation in aquatic organisms and the food chainExtreme stability and resistance to boiling and standard water chlorinationChronic low-dose exposure risk via drinking water and food
06

Interacting drugs

Activated charcoal

4 more in the full profile.

07

Biomarkers

Serum Alanine Aminotransferase (ALT)Serum Aspartate Aminotransferase (AST)Microcystin-protein adducts (in liver tissue)Lactate Dehydrogenase (LDH)Total Bilirubin

Beyond the preview

Go deeper on Microcystin (MC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microcystin (MC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call